search
Back to results

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

Primary Purpose

Delirium

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Rivastigmine patch
Sponsored by
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium focused on measuring acetylcholinesterase inhibitors, rivastigmine patch, post-operational delirium

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Consecutively enrolled the patients who is going to operation after femur neck fracture.
  • Patients agree to the informed consent.

Exclusion Criteria:

  • depressive mood and their geriatric depression scale is over 6 / 15.
  • Their Korean version MMSE(minimental status examination) are over 25, or global dementia scale (GDS) are under 3 or over 5.
  • any delirious state at pre-operation period by DSM IV and CAM (Confusion Assessment Method)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Patch applied patients

    Patch non-applied patients

    Arm Description

    The investigators had enrolled consecutively the patients who were going to operation after femur neck fracture. Participants were applied the 5 unit rivastigmine patches from 3 days before and 7 days after the femur neck operation.

    The participants who were going to operation after femur neck fracture were not applied the rivastigmine patches.

    Outcomes

    Primary Outcome Measures

    the number of participants with delirium
    investigators evaluated the delirium frequency in rivastigmine applied participants comparing with non-applied participants.

    Secondary Outcome Measures

    delirium severity using delirium rating scale
    to compare the severity of delirium in rivastigmine patch applied participants with non-applied

    Full Information

    First Posted
    April 2, 2015
    Last Updated
    April 7, 2015
    Sponsor
    Chung-Ang University Hosptial, Chung-Ang University College of Medicine
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02413554
    Brief Title
    Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.
    Official Title
    Rivastigmine Patch Effect on the Post-operative Delirium Limited to Femur Neck Fracture Operation in Patients at Risk of Dementia.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    April 2013 (undefined)
    Primary Completion Date
    March 2014 (Actual)
    Study Completion Date
    April 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Delirium is a common and serious condition and is associated with adverse outcome. The elderly who have cognitive dysfunction are expected to show delirium more frequently. It is most likely that delirium represents a response to impaired cholinergic neurotransmission. Investigators aimed to establish the preventive effect of the cholinesterase inhibitor, rivastigmine patch, on the post-operative delirium limited to femur neck fracture operation in patients at risk of dementia.
    Detailed Description
    Investigators evaluated the delirium prevention effect of rivastigmine patch in patients with femur neck fracture and cognitive impairment. Investigators measured the frequency and severity of post-operation delirium in the patch applied and non-applied subjects.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Delirium
    Keywords
    acetylcholinesterase inhibitors, rivastigmine patch, post-operational delirium

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    62 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Patch applied patients
    Arm Type
    Experimental
    Arm Description
    The investigators had enrolled consecutively the patients who were going to operation after femur neck fracture. Participants were applied the 5 unit rivastigmine patches from 3 days before and 7 days after the femur neck operation.
    Arm Title
    Patch non-applied patients
    Arm Type
    No Intervention
    Arm Description
    The participants who were going to operation after femur neck fracture were not applied the rivastigmine patches.
    Intervention Type
    Drug
    Intervention Name(s)
    Rivastigmine patch
    Other Intervention Name(s)
    exelon patch
    Intervention Description
    acetylcholine esterase inhibitor
    Primary Outcome Measure Information:
    Title
    the number of participants with delirium
    Description
    investigators evaluated the delirium frequency in rivastigmine applied participants comparing with non-applied participants.
    Time Frame
    up to 7th days
    Secondary Outcome Measure Information:
    Title
    delirium severity using delirium rating scale
    Description
    to compare the severity of delirium in rivastigmine patch applied participants with non-applied
    Time Frame
    up to 7th days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Consecutively enrolled the patients who is going to operation after femur neck fracture. Patients agree to the informed consent. Exclusion Criteria: depressive mood and their geriatric depression scale is over 6 / 15. Their Korean version MMSE(minimental status examination) are over 25, or global dementia scale (GDS) are under 3 or over 5. any delirious state at pre-operation period by DSM IV and CAM (Confusion Assessment Method)
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Young Chul Youn, MD, PhD
    Organizational Affiliation
    Dept of Neurology, Chung-Ang University Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

    We'll reach out to this number within 24 hrs